These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11730823)

  • 1. Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men.
    Hislop MS; St Clair Gibson A; Lambert MI; Noakes TD; Marais AD
    Atherosclerosis; 2001 Dec; 159(2):425-32. PubMed ID: 11730823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
    Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
    Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of anabolic-androgenic steroid use or gonadal testosterone suppression on serum leptin concentration in men.
    Hislop MS; Ratanjee BD; Soule SG; Marais AD
    Eur J Endocrinol; 1999 Jul; 141(1):40-6. PubMed ID: 10407221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-release niacin treatment of the atherogenic lipid profile and lipoprotein(a) in diabetes.
    Pan J; Van JT; Chan E; Kesala RL; Lin M; Charles MA
    Metabolism; 2002 Sep; 51(9):1120-7. PubMed ID: 12200755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids.
    Webb OL; Laskarzewski PM; Glueck CJ
    Metabolism; 1984 Nov; 33(11):971-5. PubMed ID: 6493049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a).
    Superko HR; Krauss RM
    J Am Coll Cardiol; 2000 Feb; 35(2):321-6. PubMed ID: 10676676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes.
    Pan J; Lin M; Kesala RL; Van J; Charles MA
    Diabetes Obes Metab; 2002 Jul; 4(4):255-61. PubMed ID: 12099974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term low- and high-fat diets on low-density lipoprotein particle size in normolipidemic subjects.
    Guay V; Lamarche B; Charest A; Tremblay AJ; Couture P
    Metabolism; 2012 Jan; 61(1):76-83. PubMed ID: 21816443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein (a) and cholesterol in body builders using anabolic androgenic steroids.
    Cohen LI; Hartford CG; Rogers GG
    Med Sci Sports Exerc; 1996 Feb; 28(2):176-9. PubMed ID: 8775151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM.
    Langlois MR; Nordestgaard BG; Langsted A; Chapman MJ; Aakre KM; Baum H; Borén J; Bruckert E; Catapano A; Cobbaert C; Collinson P; Descamps OS; Duff CJ; von Eckardstein A; Hammerer-Lercher A; Kamstrup PR; Kolovou G; Kronenberg F; Mora S; Pulkki K; Remaley AT; Rifai N; Ros E; Stankovic S; Stavljenic-Rukavina A; Sypniewska G; Watts GF; Wiklund O; Laitinen P;
    Clin Chem Lab Med; 2020 Mar; 58(4):496-517. PubMed ID: 31855562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of extended-release niacin on the postprandial metabolism of Lp(a) and ApoB-100-containing lipoproteins in statin-treated men with type 2 diabetes mellitus.
    Ooi EM; Watts GF; Chan DC; Pang J; Tenneti VS; Hamilton SJ; McCormick SP; Marcovina SM; Barrett PH
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2686-93. PubMed ID: 26515419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL physical properties, lipoprotein and Lp(a) levels in acromegalic patients. Effects of octreotide therapy. Italian Multicenter Octreotide Study Group.
    Arosio M; Sartore G; Rossi CM; Casati G; Faglia G; Manzato E
    Atherosclerosis; 2000 Aug; 151(2):551-7. PubMed ID: 10924734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a).
    Svensson J; Jansson JO; Ottosson M; Johannsson G; Taskinen MR; Wiklund O; Bengtsson BA
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2028-33. PubMed ID: 10372705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
    Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
    Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density-lipoprotein cholesterol in bodybuilders v powerlifters. Negative effects of androgen use.
    Hurley BF; Seals DR; Hagberg JM; Goldberg AC; Ostrove SM; Holloszy JO; Wiest WG; Goldberg AP
    JAMA; 1984 Jul; 252(4):507-13. PubMed ID: 6737643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects.
    Marcoux C; Lussier-Cacan S; Davignon J; Cohn JS
    Biochim Biophys Acta; 1997 Jun; 1346(3):261-74. PubMed ID: 9219911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.